Though Boston Scientific brought in $4.66 billion in revenue for the first quarter of 2025, up 20.9% year over year, the medical devicemaker is bracing for a potential $200 million hit in the second ...

Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm ...

The Smith Center for Outcomes Research in Cardiology at BIDMC brings together physicians & researchers to examine pressing ...

Boston Scientific BSX has been gaining from new product launches and accretive acquisitions. International expansion remains ...

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a ...

Facing White House cuts, New England labs are looking to foundations, industry, and even their university hosts to bankroll ...

The risk of developing blood cancer increases with age. The finding that a molecule from gut bacteria plays a part points to ...

Boston Scientific today shared new clinical data supporting multiple therapies at the Heart Rhythm Society (HRS) 2025 Meeting ...

Boston Scientific said that while tariffs pose “unfortunate” headwinds—which are poised to add about $200 million to the cost ...